$41.71
Avidity Biosciences Inc is a biotechnology business based in the US. Avidity Biosciences Inc shares (RNA) are listed on the NASDAQ and all prices are listed in US Dollars. Avidity Biosciences Inc employs 253 staff and has a trailing 12-month revenue of around $10.6 million.
Our top picks for where to buy Avidity Biosciences Inc stock
How to buy Avidity Biosciences Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RNA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Avidity Biosciences Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Avidity Biosciences Inc stock price (NASDAQ: RNA)
Use our graph to track the performance of RNA stocks over time.Avidity Biosciences Inc shares at a glance
Latest market close | $40.99 |
---|---|
52-week range | $4.83 - $48.80 |
50-day moving average | $43.29 |
200-day moving average | $24.68 |
Wall St. target price | $66.80 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.95 |
Is it a good time to buy Avidity Biosciences Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Avidity Biosciences Inc price performance over time
Historical closes compared with the close of $40.99 from 2024-09-03
1 week (2024-08-29) | -3.87% |
---|---|
1 month (2024-08-05) | -2.87% |
3 months (2024-06-05) | 46.71% |
6 months (2024-03-05) | 114.16% |
1 year (2023-09-05) | 450.94% |
---|---|
2 years (2022-09-02) | 92.80% |
3 years (2021-09-03) | 113.05% |
5 years (2019-09-01) | N/A |
Avidity Biosciences Inc financials
Revenue TTM | $10.6 million |
---|---|
Gross profit TTM | $-141,180,000 |
Return on assets TTM | -18.2% |
Return on equity TTM | -28.36% |
Profit margin | 0% |
Book value | $11.18 |
Market Capitalization | $5.2 billion |
TTM: trailing 12 months
Avidity Biosciences Inc share dividends
We're not expecting Avidity Biosciences Inc to pay a dividend over the next 12 months.
Avidity Biosciences Inc share price volatility
Over the last 12 months, Avidity Biosciences Inc's shares have ranged in value from as little as $4.825 up to $48.8012. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avidity Biosciences Inc's is 0.896. This would suggest that Avidity Biosciences Inc's shares are less volatile than average (for this exchange).
Avidity Biosciences Inc overview
Avidity Biosciences, Inc. , a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc.
Frequently asked questions
nullWhat percentage of Avidity Biosciences Inc is owned by insiders or institutions?
Currently 4.889% of Avidity Biosciences Inc shares are held by insiders and 97.077% by institutions. How many people work for Avidity Biosciences Inc?
Latest data suggests 253 work at Avidity Biosciences Inc. When does the fiscal year end for Avidity Biosciences Inc?
Avidity Biosciences Inc's fiscal year ends in December. Where is Avidity Biosciences Inc based?
Avidity Biosciences Inc's address is: 10578 Science Center Drive, San Diego, CA, United States, 92121 What is Avidity Biosciences Inc's ISIN number?
Avidity Biosciences Inc's international securities identification number is: US05370A1088 What is Avidity Biosciences Inc's CUSIP number?
Avidity Biosciences Inc's Committee on Uniform Securities Identification Procedures number is: N71546100
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question